Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Second Chance for Moms Act of 2025 This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Introduced
Jan 28, 2025
Last Action
Jan 28, 2025
Session
119th Congress
Sponsors
1 primary · 13 co
Passage Probability
2% — Very Low
Introduced in House
Referred to the House Committee on Energy and Commerce.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProReferred to the House Committee on Energy and Commerce.